Roche

NEWS

Biotech Bay

The Possibility of Simultaneous COVID-19 and Flu Infections Poses a Double-Threat

As we head into cold and flu season, the question arises: Can you get COVID-19 and the flu at the same time?

September 4, 2020

3 min read

Mark Terry

Drug Development

Biopharma Update on the Novel Coronavirus: September 4

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.

September 3, 2020

3 min read

BioSpace Editorial Staff

FDA

FDA Approves New HIV-1/HIV-2 Qualitative Test from Roche

This test will give healthcare providers a single result to confirm an HIV diagnosis with patients and differentiate between HIV-1 and HIV-2.

September 2, 2020

2 min read

Krystle Vermes

Policy

FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS

August has been a busy month for the U.S. Food and Drug Administration. The final two weeks are marked by a number of PDUFA dates, although a few of those drugs have already been approved.

August 21, 2020

3 min read

Mark Terry

Business

Regeneron and Roche Partner to Increase Supply of COVID-19 Antibody Cocktail

Regeneron will distribute REGN-COV-2 in the U.S. and Roche will handle distribution outside the U.S.

August 19, 2020

3 min read

Mark Terry

Job Trends

Celleron Therapeutics Gains Worldwide Rights to Shelved Roche Drug

Celleron Therapeutics signed a licensing agreement with Roche for the worldwide rights to cancer drug emactuzumab, a monoclonal antibody directed against colony-stimulating factor 1 (CSF-1R) expressed on macrophages.

August 12, 2020

2 min read

Alex Keown

Drug Development

Roche’s Actemra Misses the Mark in Phase III COVID-19 Associated Pneumonia Study

Roche’s Actemra failed to meet its primary and secondary endpoints in a late-stage study involving hospitalized patients with severe COVID-19 associated pneumonia.

July 29, 2020

3 min read

Alex Keown